[{"id":"8a37d0f9-8abd-490b-aee8-74694dd7e0ba","acronym":"","url":"https://clinicaltrials.gov/study/NCT03859752","created_at":"2021-01-18T19:02:32.942Z","updated_at":"2024-07-02T16:35:36.034Z","phase":"Phase 1","brief_title":"TR1801-ADC in Patients With Tumors That Express c-Met","source_id_and_acronym":"NCT03859752","lead_sponsor":"Open Innovation Partners, Inc.","biomarkers":" MET","pipe":" | ","alterations":" MET expression","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TR1801-ADC"],"overall_status":"Suspended","enrollment":" Enrollment 15","initiation":"Initiation: 08/14/2019","start_date":" 08/14/2019","primary_txt":" Primary completion: 07/04/2023","primary_completion_date":" 07/04/2023","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2023-09-22"}]